Covered recipient · General Payments record
AMANDA LARSEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,274.68
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $889.72 | 52 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $213.24 | 22 |
| EISAI INC. | $132.74 | 6 |
| Lilly USA, LLC | $99.29 | 5 |
| EMD Serono, Inc. | $71.28 | 3 |
| Biogen, Inc. | $66.28 | 3 |
| UCB, Inc. | $55.25 | 2 |
| PFIZER INC. | $41.18 | 2 |
| Alexion Pharmaceuticals, Inc. | $27.45 | 1 |
| Celgene Corporation | $27.09 | 1 |
| Life Molecular Imaging Ltd | $26.16 | 1 |
| ARGENX US, INC. | $25.73 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.89 | 1 |
| Kyowa Kirin, Inc. | $20.76 | 1 |
| Medtronic, Inc. | $20.66 | 1 |
| ACADIA Pharmaceuticals Inc | $20.42 | 1 |
| Teva Pharmaceuticals USA, Inc. | $18.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.88 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510517 | CMS |
| ABBVIE INC. | $7.18 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510519 | CMS |
| ABBVIE INC. | $2.63 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510521 | CMS |
| ABBVIE INC. | $19.90 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510523 | CMS |
| ABBVIE INC. | $7.39 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510525 | CMS |
| ABBVIE INC. | $8.37 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510527 | CMS |
| ABBVIE INC. | $1.74 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510529 | CMS |
| ABBVIE INC. | $16.42 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510531 | CMS |
| ABBVIE INC. | $3.64 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510533 | CMS |
| ABBVIE INC. | $9.00 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510535 | CMS |
| ABBVIE INC. | $13.00 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510537 | CMS |
| ABBVIE INC. | $13.03 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510539 | CMS |
| ABBVIE INC. | $23.51 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510541 | CMS |
| ABBVIE INC. | $2.32 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510543 | CMS |
| ABBVIE INC. | $17.73 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510545 | CMS |
| ABBVIE INC. | $9.22 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510547 | CMS |
| ABBVIE INC. | $12.07 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510549 | CMS |
| ABBVIE INC. | $7.27 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510551 | CMS |
| ABBVIE INC. | $8.47 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510553 | CMS |
| ABBVIE INC. | $2.16 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510555 | CMS |
| ABBVIE INC. | $7.49 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510557 | CMS |
| ABBVIE INC. | $11.82 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107510559 | CMS |
| ACADIA Pharmaceuticals Inc | $20.42 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148007645 | CMS |
| Alexion Pharmaceuticals, Inc. | $27.45 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093998542 | CMS |
| ARGENX US, INC. | $25.73 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142150688 | CMS |
| Biogen, Inc. | $18.28 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104817992 | CMS |
| Biogen, Inc. | $22.85 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104864008 | CMS |
| Biogen, Inc. | $25.15 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104817994 | CMS |
| Celgene Corporation | $27.09 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101177432 | CMS |
| Eisai Inc. | $19.72 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110791938 | CMS |
| Eisai Inc. | $22.64 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110791940 | CMS |
| Eisai Inc. | $23.49 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110791942 | CMS |
| Eisai Inc. | $5.78 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110791936 | CMS |
| Eisai Inc. | $32.81 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110791944 | CMS |
| Eisai Inc. | $28.30 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110791946 | CMS |
| EMD Serono, Inc. | $27.87 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120237666 | CMS |
| EMD Serono, Inc. | $23.41 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120237664 | CMS |
| EMD Serono, Inc. | $20.00 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120218276 | CMS |
| Kyowa Kirin, Inc. | $20.76 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127046349 | CMS |
| Life Molecular Imaging Ltd | $26.16 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154809150 | CMS |
| Lilly USA, LLC | $22.46 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135491314 | CMS |
| Lilly USA, LLC | $19.94 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135464910 | CMS |
| Lilly USA, LLC | $13.84 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135519806 | CMS |
| Lilly USA, LLC | $21.30 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135506766 | CMS |
| Lilly USA, LLC | $21.75 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135528697 | CMS |
| Medtronic, Inc. | $20.66 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116941776 | CMS |
| PFIZER INC. | $17.82 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131101183 | CMS |
| PFIZER INC. | $23.36 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132095957 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.89 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137779118 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.30 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151609790 | CMS |
| UCB, Inc. | $25.16 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143042907 | CMS |
| UCB, Inc. | $30.09 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143042909 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.